The consideration moving from Healthscope to the shareholders in Symbion Health was to be a mixture of cash and shares in Healthscope. By cl 5.1(c) of the TID, Symbion Health undertakes, relevantly, to implement the Capital Reduction and the Share Distribution Dividend. Idameneo seeks an injunction restraining Symbion Health from paying, and the Directors from causing or procuring it to pay, the Symbion Health Break Fee. 13 After completion of the Diagnostics Transaction, Symbion Health would be left owning the C & P Businesses. 81 The first reason for this conclusion relates to the distinctness of the two resolutions.